BNP Paribas Exane Adjusts Clorox Price Target to $95 From $97, Maintains Neutral Rating
BNP Paribas Exane has reduced its price target for The Clorox Company (CLX) to $95 from $97, while maintaining a Neutral rating on the stock. This adjustment reflects a recent shift in analyst sentiment, as other firms like UBS and JPMorgan have also revised …